Weill Cornell Medicine Urology
Weill Cornell Medicine Urology
Research on SPOP Prostate Cancer Subtype Prognosis and PSA levels

Research on SPOP Prostate Cancer Subtype Prognosis and PSA levels

Find a Physician

FIND A PHYSICIAN

Quickly search our world-class physicians and faculty by keyword, location and insurance provider.

Search

Dr. Christopher Barbieri was interviewed as a co-senior author on new prostate cancer research from Weill Cornell Medicine & colleagues, regarding the interpretation of PSA levels in patients with the SPOP prostate cancer subtype.

"These findings are counterintuitive," said co-senior author Dr. Christopher Barbieri, an assistant professor of urology at Weill Cornell Medicine. "In general, if your PSA is higher, the cancer is more dangerous. However, this study found that tumors associated with a high PSA and SPOP mutations were less dangerous."

Read the full article here on WCM Newsroom: https://news.weill.cornell.edu/news/2018/07/despite-high-psa-level-prost...

The study was published in JCO Precision Oncology and can be viewed here: http://ascopubs.org/doi/10.1200/PO.18.00036

Find a Physician FIND A PHYSICIAN

© 2016 Weill Cornell Medicine All rights reserved.